Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

Analysis of Liquidity Ratios
Quarterly Data

Microsoft Excel

Liquidity Ratios (Summary)

Elevance Health Inc., liquidity ratios (quarterly data)

Microsoft Excel
Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Current ratio 1.44 1.41 1.44 1.43 1.40 1.35 1.36 1.36 1.47 1.48 1.49 1.57 1.55 1.59 1.64 1.53 1.65 1.70 1.64 1.61
Quick ratio 1.30 1.29 1.32 1.31 1.27 1.21 1.22 1.23 1.33 1.33 1.35 1.43 1.42 1.45 1.49 1.37 1.52 1.58 1.51 1.49
Cash ratio 0.87 0.90 0.92 0.91 0.86 0.87 0.86 0.86 0.95 0.97 0.97 1.08 1.04 1.04 1.10 0.95 1.08 1.14 1.07 1.04

Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Elevance Health Inc. current ratio deteriorated from Q2 2023 to Q3 2023 but then improved from Q3 2023 to Q4 2023 not reaching Q2 2023 level.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Elevance Health Inc. quick ratio deteriorated from Q2 2023 to Q3 2023 but then slightly improved from Q3 2023 to Q4 2023.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Elevance Health Inc. cash ratio deteriorated from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.

Current Ratio

Elevance Health Inc., current ratio calculation (quarterly data)

Microsoft Excel
Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Current assets 60,029 61,185 59,743 59,823 55,617 55,603 53,655 53,897 51,122 51,904 50,238 54,495 45,751 45,450 46,764 41,256 39,033 39,504 37,805 36,611
Current liabilities 41,791 43,337 41,571 41,889 39,696 41,287 39,308 39,733 34,885 35,162 33,794 34,749 29,453 28,561 28,522 27,039 23,617 23,234 23,090 22,682
Liquidity Ratio
Current ratio1 1.44 1.41 1.44 1.43 1.40 1.35 1.36 1.36 1.47 1.48 1.49 1.57 1.55 1.59 1.64 1.53 1.65 1.70 1.64 1.61
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories 1.64 1.74 1.64 1.68 1.63 1.86 2.01 1.85 1.85 1.83 1.79 1.75 1.72 1.70 1.57 1.43 1.44 1.54 1.68 1.58
Cigna Group 0.77 0.73 0.73 0.72 0.73 0.73 0.83 0.81 0.83 0.70 0.72 0.76 0.77 0.79 0.83 0.76 0.74 0.61 0.65 0.64
CVS Health Corp. 0.86 0.86 0.86 0.92 0.94 0.94 0.91 0.88 0.88 0.94 0.95 0.93 0.91 0.95 0.98 0.99 0.94 0.92 0.95 0.95
Danaher Corp. 1.68 2.26 2.08 1.89 1.89 1.78 1.75 1.68 1.43 1.48 2.26 2.05 1.86 2.08 2.20 1.32 5.19 3.43 2.32 2.18
Humana Inc. 1.59 1.37 1.37 1.39 1.52 1.35 1.53 1.53 1.62 1.72 1.71 1.67 1.77 1.81 1.69 1.66 1.82 1.83 1.75 1.65
Intuitive Surgical Inc. 4.76 5.31 5.22 5.26 4.40 5.10 5.36 5.22 5.08 5.58 5.99 6.71 6.86 7.04 6.38 4.96 4.53 4.64 5.04 5.44
Medtronic PLC 2.39 1.76 1.76 1.58 1.86 2.61 2.91 2.89 2.65 2.10 2.16 1.87 2.13 2.75 2.77 2.67 2.59 2.36 2.56 2.46
UnitedHealth Group Inc. 0.79 0.80 0.80 0.81 0.77 0.82 0.77 0.78 0.79 0.77 0.77 0.74 0.74 0.82 0.84 0.75 0.69 0.70 0.67 0.73

Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q4 2023 Calculation
Current ratio = Current assets ÷ Current liabilities
= 60,029 ÷ 41,791 = 1.44

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Elevance Health Inc. current ratio deteriorated from Q2 2023 to Q3 2023 but then improved from Q3 2023 to Q4 2023 not reaching Q2 2023 level.

Quick Ratio

Elevance Health Inc., quick ratio calculation (quarterly data)

Microsoft Excel
Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Cash and cash equivalents 6,526 10,919 9,991 10,142 7,387 8,872 6,456 6,161 4,880 5,490 5,258 9,326 5,741 3,984 6,028 5,345 4,937 4,190 4,078 4,482
Fixed maturity securities 29,614 27,811 28,021 27,636 25,952 25,526 25,765 26,219 26,267 26,348 25,848 24,555 23,433 22,707 22,018 19,881 19,676 19,960 19,123 17,795
Equity securities 229 165 272 392 953 1,503 1,572 1,662 1,881 2,119 1,746 3,630 1,559 3,075 3,470 570 1,009 2,300 1,492 1,211
Premium receivables 7,902 7,883 7,431 8,246 7,083 6,682 6,757 7,349 5,681 6,008 5,834 6,111 5,279 5,343 5,456 5,786 5,173 4,782 4,751 5,049
Self-funded receivables 4,558 3,756 3,896 3,786 4,663 3,873 3,844 3,979 4,010 3,349 3,605 3,109 2,849 2,985 2,460 2,613 2,411 2,555 2,534 2,491
Other receivables 5,405 5,293 5,196 4,678 4,298 3,651 3,600 3,334 3,749 3,450 3,246 3,071 2,830 3,209 3,072 2,926 2,807 3,038 2,801 2,800
Total quick assets 54,234 55,827 54,807 54,880 50,336 50,107 47,994 48,704 46,468 46,764 45,537 49,802 41,691 41,303 42,504 37,121 36,013 36,825 34,779 33,828
 
Current liabilities 41,791 43,337 41,571 41,889 39,696 41,287 39,308 39,733 34,885 35,162 33,794 34,749 29,453 28,561 28,522 27,039 23,617 23,234 23,090 22,682
Liquidity Ratio
Quick ratio1 1.30 1.29 1.32 1.31 1.27 1.21 1.22 1.23 1.33 1.33 1.35 1.43 1.42 1.45 1.49 1.37 1.52 1.58 1.51 1.49
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories 1.00 1.04 1.00 1.07 1.06 1.22 1.33 1.21 1.28 1.25 1.19 1.16 1.14 1.01 0.93 0.83 0.88 0.93 0.98 0.94
Cigna Group 0.54 0.61 0.61 0.59 0.58 0.61 0.52 0.48 0.48 0.58 0.59 0.64 0.66 0.46 0.50 0.42 0.41 0.51 0.53 0.53
CVS Health Corp. 0.59 0.60 0.59 0.61 0.62 0.64 0.62 0.54 0.55 0.59 0.58 0.54 0.53 0.58 0.63 0.60 0.52 0.52 0.54 0.55
Danaher Corp. 1.18 1.76 1.52 1.34 1.30 1.19 1.13 1.08 0.89 0.93 1.67 1.51 1.36 1.52 1.59 0.92 4.68 2.99 1.78 1.58
Humana Inc. 1.24 1.15 1.16 1.18 1.20 1.13 1.21 1.21 1.20 1.32 1.28 1.26 1.37 1.47 1.35 1.29 1.47 1.51 1.36 1.32
Intuitive Surgical Inc. 3.83 4.44 4.36 4.30 3.56 4.19 4.49 4.40 4.34 4.66 5.12 5.76 5.96 5.93 5.40 4.00 3.75 3.80 4.15 4.53
Medtronic PLC 1.54 1.18 1.18 1.01 1.30 1.87 2.07 2.06 1.91 1.58 1.63 1.37 1.50 2.05 2.02 1.95 1.90 1.69 1.88 1.83
UnitedHealth Group Inc. 0.73 0.75 0.74 0.75 0.70 0.77 0.71 0.72 0.72 0.71 0.71 0.68 0.68 0.75 0.76 0.66 0.63 0.64 0.62 0.66

Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q4 2023 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 54,234 ÷ 41,791 = 1.30

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Elevance Health Inc. quick ratio deteriorated from Q2 2023 to Q3 2023 but then slightly improved from Q3 2023 to Q4 2023.

Cash Ratio

Elevance Health Inc., cash ratio calculation (quarterly data)

Microsoft Excel
Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Cash and cash equivalents 6,526 10,919 9,991 10,142 7,387 8,872 6,456 6,161 4,880 5,490 5,258 9,326 5,741 3,984 6,028 5,345 4,937 4,190 4,078 4,482
Fixed maturity securities 29,614 27,811 28,021 27,636 25,952 25,526 25,765 26,219 26,267 26,348 25,848 24,555 23,433 22,707 22,018 19,881 19,676 19,960 19,123 17,795
Equity securities 229 165 272 392 953 1,503 1,572 1,662 1,881 2,119 1,746 3,630 1,559 3,075 3,470 570 1,009 2,300 1,492 1,211
Total cash assets 36,369 38,895 38,284 38,170 34,292 35,901 33,793 34,042 33,028 33,957 32,852 37,511 30,733 29,766 31,516 25,796 25,622 26,450 24,693 23,488
 
Current liabilities 41,791 43,337 41,571 41,889 39,696 41,287 39,308 39,733 34,885 35,162 33,794 34,749 29,453 28,561 28,522 27,039 23,617 23,234 23,090 22,682
Liquidity Ratio
Cash ratio1 0.87 0.90 0.92 0.91 0.86 0.87 0.86 0.86 0.95 0.97 0.97 1.08 1.04 1.04 1.10 0.95 1.08 1.14 1.07 1.04
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories 0.53 0.54 0.57 0.66 0.66 0.74 0.75 0.65 0.78 0.75 0.71 0.67 0.60 0.46 0.46 0.34 0.38 0.41 0.37 0.36
Cigna Group 0.18 0.20 0.22 0.20 0.17 0.19 0.11 0.12 0.14 0.13 0.15 0.24 0.32 0.15 0.20 0.13 0.14 0.17 0.17 0.20
CVS Health Corp. 0.14 0.20 0.21 0.24 0.23 0.28 0.22 0.16 0.18 0.20 0.17 0.15 0.18 0.19 0.27 0.21 0.15 0.14 0.17 0.16
Danaher Corp. 0.71 1.31 1.02 0.85 0.71 0.64 0.53 0.49 0.32 0.35 1.07 0.93 0.82 0.94 0.99 0.52 4.04 2.40 1.08 0.84
Humana Inc. 1.13 1.09 1.11 1.06 1.10 1.07 1.02 1.02 1.08 1.20 1.12 1.12 1.29 1.39 1.22 1.16 1.37 1.44 1.28 1.15
Intuitive Surgical Inc. 3.15 3.86 3.77 3.59 2.90 3.50 3.78 3.58 3.66 3.98 4.42 5.04 5.30 5.27 4.85 3.44 3.13 3.11 3.37 3.79
Medtronic PLC 0.88 0.77 0.79 0.63 0.85 1.26 1.37 1.36 1.27 1.17 1.18 0.99 1.06 1.33 1.27 1.25 1.16 1.03 1.20 1.21
UnitedHealth Group Inc. 0.34 0.42 0.44 0.43 0.36 0.46 0.36 0.37 0.36 0.35 0.35 0.33 0.33 0.37 0.42 0.35 0.28 0.30 0.32 0.32

Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q4 2023 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 36,369 ÷ 41,791 = 0.87

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Elevance Health Inc. cash ratio deteriorated from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.